FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology, endocrinology, and can be used for correction of the blood microvesicle level in the patients with arterial hypertension, dyslipidemia and abdominal obesity. That is ensured by the administration of Irbesartan in dosage 150 mg once in the morning and Metformin 500 mg twice a day with underlying graduated physical activity for at least 5 weeks.
EFFECT: method ensures reduced risk of thrombotic complications, higher clinical effectiveness and improved prognosis in the case patients due to the rating correction of the blood microvesicle level and decrease in the blood haemocoagulation potential.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400228C1 |
METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND ABDOMINAL OBESITY | 2009 |
|
RU2393858C1 |
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, DYSLIPIDEMIA AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400209C1 |
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND TYPE II DIABETES MELLITUS | 2009 |
|
RU2400230C1 |
METHOD OF BLOOD MICROVESICLE LEVEL NORMALISATION IN ARTERIAL HYPERTESION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2398573C1 |
METHOD FOR DECREASING BLOOD MICROVESCILE LEVEL IN ARTERIAL HYPERTENSION AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2393859C1 |
METHOD OF NITROGEN OXIDE DELIVERY NORMALISATION IN VESSELS OF PATIENT SUFFERING FROM ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME | 2006 |
|
RU2330650C2 |
METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE | 2009 |
|
RU2400204C1 |
METHOD FOR CORRECTION OF BLOOD MICROVESCILE LEVEL IN DYSLIPIDEMIA AND ABDOMINAL OBESITY | 2009 |
|
RU2393856C1 |
METHOD OF FAST NORMALISATION OF ARACHIDONIC ACID METABOLISM FOR PATIENTS SUFFERING FROM ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2330652C1 |
Authors
Dates
2010-09-27—Published
2009-04-17—Filed